Page last updated: 2024-08-26

artesunic acid and Invasiveness, Neoplasm

artesunic acid has been researched along with Invasiveness, Neoplasm in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's7 (87.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pan, J; Zheng, L1
Baoxian, T; Dong, H; Jinbo, Y; Jing, W; Min, M; Rongbo, Z; Ru, C; Runpeng, Z; Shengfa, N; Weidong, H; Xuewei, X; Yingru, X1
Beccafico, S; Donato, R; Marchetti, MC; Morozzi, G; Riccardi, C; Sidoni, A; Sorci, G1
Choi, HY; Jeon, SS; Jeong, BC; Jeong, DE; Joo, KM; Lee, HW; Lee, SJ; Lim, JE; Lim, S; Nam, DH; Song, HJ1
Baumann, I; Edler, L; Hoth, S; König, M; Sertel, S; von Hagens, C; Walter-Sack, I1
Bai, Y; Dong, J; Du, Z; Guo, G; Hu, X; Huang, X; Jia, J; Lian, S; Ma, N; Shi, R; Song, B; Wang, M; Yang, B; Zhang, Y1
Allgayer, H; Asangani, IA; Efferth, T; Rasheed, SA1
Chen, HH; Lou, XE; Wu, GD; Zhou, HJ1

Trials

1 trial(s) available for artesunic acid and Invasiveness, Neoplasm

ArticleYear
Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study.
    Cancer chemotherapy and pharmacology, 2016, Volume: 77, Issue:2

    Topics: Adult; Antimalarials; Artemisinins; Artesunate; Audiometry; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Treatment Outcome; Vertigo

2016

Other Studies

7 other study(ies) available for artesunic acid and Invasiveness, Neoplasm

ArticleYear
The Anti-malarial Drug Artesunate Blocks Wnt/β-catenin Pathway and Inhibits Growth, Migration and Invasion of Uveal Melanoma Cells.
    Current cancer drug targets, 2018, Volume: 18, Issue:10

    Topics: Adult; Analysis of Variance; Antimalarials; Antineoplastic Agents; Apoptosis; Artesunate; beta Catenin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Therapy, Combination; Glycogen Synthase Kinase 3 beta; Humans; Melanoma; Neoplasm Invasiveness; Phosphorylation; Signal Transduction; Uveal Neoplasms; Vincristine; Wnt Signaling Pathway

2018
Dependence of artesunate on long noncoding RNA-RP11 to inhibit epithelial-mesenchymal transition of hepatocellular carcinoma.
    Journal of cellular biochemistry, 2019, Volume: 120, Issue:4

    Topics: Artesunate; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Neoplasm Invasiveness; RNA, Long Noncoding

2019
Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells.
    Carcinogenesis, 2015, Volume: 36, Issue:9

    Topics: Acetylcysteine; Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA Damage; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Integrin beta1; Mice; MicroRNAs; Neoplasm Invasiveness; Neoplasm Transplantation; Neural Cell Adhesion Molecules; p38 Mitogen-Activated Protein Kinases; PAX7 Transcription Factor; Pyridines; Reactive Oxygen Species; Rhabdomyosarcoma, Embryonal; Transplantation, Heterologous

2015
Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.
    Oncotarget, 2015, 10-20, Volume: 6, Issue:32

    Topics: Animals; Antigens, CD; Antimalarials; Antineoplastic Agents; Artemisinins; Artesunate; Carcinoma, Renal Cell; Cell Death; Cell Line, Tumor; Cell Proliferation; Female; Human Umbilical Vein Endothelial Cells; Humans; Kidney Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Prognosis; Reactive Oxygen Species; Receptors, Transferrin; Xenograft Model Antitumor Assays

2015
Artesunate attenuates glioma proliferation, migration and invasion by affecting cellular mechanical properties.
    Oncology reports, 2016, Volume: 36, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Claudin-1; Gene Expression Regulation, Neoplastic; Glioma; Humans; Neoplasm Invasiveness; RNA, Small Interfering; Signal Transduction; Up-Regulation

2016
First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases.
    International journal of cancer, 2010, Sep-01, Volume: 127, Issue:6

    Topics: Animals; Antimalarials; Artemisinins; Artesunate; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Chick Embryo; Enzyme-Linked Immunosorbent Assay; Gene Expression Profiling; Humans; Lung Neoplasms; Matrix Metalloproteinases; Neoplasm Invasiveness; Neoplasm Metastasis; Polymerase Chain Reaction; RNA, Messenger; Urokinase-Type Plasminogen Activator

2010
Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1.
    Pharmacology, 2004, Volume: 71, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; Antimalarials; Artemisinins; Artesunate; Body Weight; Cell Differentiation; Cell Division; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Humans; Injections, Subcutaneous; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Neovascularization, Physiologic; Ovarian Neoplasms; Sesquiterpenes; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Xenograft Model Antitumor Assays

2004